Related by context. All words. (Click for frequent words.) 69 triglyceride concentrations 68 nondiabetic patients 67 elevated fasting glucose 65 glycosylated hemoglobin HbA1c 64 Hp2 2 64 inversely associated 64 hyperlipidaemia 63 glucose insulin 63 fasting hyperglycemia 63 fasting plasma 63 NNT = 63 atherogenic dyslipidemia 63 Intravenous immunoglobulin 63 umol L 63 pleiotropic effects 63 serum leptin 63 PLX STROKE targeting 63 Hypoglycaemia 63 insulin glulisine 62 hypertension diabetes mellitus 62 Plasma concentrations 62 glycated hemoglobin levels 62 metabolic parameters 62 mild renal insufficiency 62 metabolite concentrations 62 CC genotype 62 hyperglycaemia 62 hyperlipidemia hypertension 62 diabetes dyslipidemia 62 IPAH 62 CIMZIA ™ 62 fluoxetine paroxetine 62 macrovascular disease 62 plasma lipids 62 pamidronate 62 Serum concentrations 62 interleukin IL -6 62 alpha1 antitrypsin deficiency 62 sulfonylurea metformin 62 colorectal adenoma 61 gene polymorphism 61 nmol 61 impaired glucose metabolism 61 elevated triglyceride levels 61 Apidra ® 61 reduce serum phosphate 61 serum triglycerides 61 interleukin IL -# 61 dyslipidaemia 61 relapsed MM 61 folate vitamin B 61 hepatorenal syndrome 61 artery stenosis 61 unresectable tumors 61 hypercalciuria 61 5 hydroxytryptamine 61 triacylglycerol concentrations 61 diabetes mellitus DM 61 haematologic 61 diabetes mellitus hypertension 61 Subgroup analysis 61 improves insulin sensitivity 61 SGPT 61 isoprostane 61 Fasting glucose 61 Insulin detemir 61 lymphocytosis 60 autonomic dysfunction 60 mU liter 60 serum concentrations 60 hematological parameters 60 Univariate analysis 60 overt nephropathy 60 FOSRENOL ® 60 blood glucose concentrations 60 ß blockers 60 salmeterol fluticasone 60 hypocalcaemia 60 noncardiovascular mortality 60 platelet dysfunction 60 basal bolus therapy 60 CTAP# Capsules 60 Insulin sensitivity 60 euthyroid 60 Levels Linked 60 hemoglobin A1c HbA1c 60 bronchoalveolar lavage fluid 60 lipid lowering agents 60 Fasting blood glucose 60 thyrotropin levels 60 oral antidiabetic medication 60 GH deficiency 60 deoxyglucose 60 CLA supplementation 60 CI #.#-#.# [001] 60 nicardipine 60 delta gamma agonist 60 serum lipid levels 60 NPH insulin 60 adiponectin concentrations 60 glycaemia 60 insulin resistance precursor 60 echocardiographic parameters 60 dose atorvastatin 60 triiodothyronine 60 mL/min/#.# m 2 60 insulin detemir 60 leucopenia 60 acarbose 60 pioglitazone HCl 60 fasting serum 60 cell adhesion molecule 60 fasting triglyceride levels 60 stimulates insulin secretion 60 hypercholesterolemic patients 59 Mg Usa 59 Thyroxine 59 β blockers 59 6mg 59 normotensive 59 Orthostatic hypotension 59 pretreatment serum 59 tertiles 59 hypophosphatemia 59 p = .# [002] 59 fructosamine 59 vitamin B# folic acid 59 nonischemic 59 mixed hyperlipidemia 59 prospectively stratified 59 angiographically 59 congenital deficiency 59 serum phosphate 59 lispro 59 myocardial infarction ventricular fibrillation 59 biochemical relapse 59 HMG CoA reductase inhibitors 59 highest tertile 59 aminotransferase 59 vildagliptin 59 hepatic liver 59 maximally tolerated lipid lowering 59 Acute renal failure 59 SSc 59 glomerular filtration 59 Creatinine 59 hypoglycemic episodes 59 murine model 59 hyperlipidemic 59 chronic thromboembolic pulmonary 59 hypercholesterolaemia 59 Hepatotoxicity 59 leptin deficiency 59 nondiabetics 59 hypertensive rats 59 baseline FEV 59 redox active 59 Nonalcoholic Steatohepatitis 59 β carotene 59 Exclusion criteria 59 antiangiogenic therapy 59 pDC 59 serum triglyceride levels 59 -#.# mg dL [002] 59 apolipoprotein B 59 oral hypoglycemic 59 nutlin 3a 59 pravastatin therapy 59 deoxy 59 transferrin saturation 59 arachidonic acid AA 59 Polyunsaturated fat 59 elevated ALT 59 confidence interval #.#-#.# 59 nondiabetic 59 metformin sulfonylureas 59 collagenous colitis 59 plasma lipid 59 conventional DMARDs 59 systemic amyloidosis 59 abnormal lipids 59 hypertension hypercholesterolemia 59 PREZISTA r arm 59 comorbid illnesses 59 #mg sodium #mg [002] 59 bilirubin liver 59 folinic acid 59 convulsive disorders 58 μg liter 58 isoenzyme 58 Phenylketonuria PKU 58 perioperative complications 58 procollagen 58 hyperphenylalaninemia HPA due 58 macroalbuminuria 58 idiopathic thrombocytopenic purpura 58 Cystatin C 58 urinary excretion 58 Hypotension 58 anthracycline chemotherapy 58 BPS IC 58 menaquinone 58 lowest tertile 58 liver histology 58 baseline serum creatinine 58 pmol liter 58 riociguat 58 prolactin elevation 58 fasting insulin 58 Impaired glucose tolerance 58 intact parathyroid hormone 58 humoral responses 58 postprandial glycemia 58 HbA1C levels 58 clinically meaningful reductions 58 % CI #.#-#.# [008] 58 serum cortisol 58 airway hyperresponsiveness 58 APOE genotype 58 thyrotropin 58 BENICAR HCT 58 AML MDS 58 serum homocysteine 58 insulin aspart 58 graft occlusion 58 visceral metastases 58 ob ob mice 58 lanthanum carbonate 58 psoriatic arthritis PsA 58 endogenous glucose 58 polyp recurrence 58 HOMA IR 58 anagrelide 58 microangiopathy 58 systemic hypotension 58 T1c 58 COPD exacerbation 58 comorbid anxiety 58 onset diabetes mellitus 58 ionotropic 58 budesonide pMDI 58 Arch Intern Med 58 REYATAZ r arm 58 lacunar 58 decompensated cirrhosis 58 Lipoic acid 58 HIV HCV coinfected 58 gross hematuria 58 Soy isoflavones 58 Multivariate analyzes 58 diuretics beta blockers 58 metabolizing enzyme 58 somatostatin analog 58 Non Responders 58 cirrhotic 58 stage IIIb IV 58 % CI #.#-#.# [007] 58 SGOT 58 ALT elevation 58 oral antidiabetes 58 VLDL cholesterol 58 elevated transaminases 58 beta carotene supplementation 58 serum urate levels 58 glucocorticoid induced 58 aged ≥ 58 angiotensin receptor blockers ARB 58 intraabdominal 58 thyroid hormone replacement 58 Monocyte 58 obesity dyslipidemia 58 histologically confirmed 58 Thiazolidinediones 58 HBeAg 58 HbA 1c levels 58 E selectin 58 lymphocyte counts 58 virologic breakthrough 58 acromegalic patients 58 recurrent acute pancreatitis 58 homocysteine concentrations 58 HeFH 58 Cardiorespiratory fitness 58 sulphonylureas 58 6 phosphate dehydrogenase 58 glycated hemoglobin HbA1c 58 symptomatic VTE 58 Hyperlipidemia 58 serum creatinine levels 58 primary aldosteronism 58 containing abacavir 58 gestational diabetes mellitus 58 #mg #mg #mg [003] 58 thrombocytosis 58 acid ethyl esters 58 Retreatment 58 CVD mortality 58 beta carotene lycopene 58 colorectal bowel 58 Elevated serum 58 nodal metastasis 58 intracranial hemorrhage ICH 58 T1DM 58 Wistar rats 57 Glimepiride 57 CIMZIA TM certolizumab pegol 57 serum lipid 57 thrombocytopenia neutropenia 57 Thal Dex 57 flavonoid intake 57 TIMP 1 57 achieved CCyR 57 serum PTH 57 bronchoalveolar lavage 57 endothelial activation 57 Acute Myeloid Leukaemia AML 57 ethyl ester 57 undergoing peritoneal dialysis 57 nonalcoholic steatohepatitis 57 glycosylated hemoglobin levels 57 antidiabetic medication 57 shorter telomere length 57 N telopeptide 57 familial aggregation 57 J Am Soc 57 Lipodystrophy 57 protein excretion 57 mcg BID 57 thyroid deficiency 57 inhaled budesonide 57 nephrolithiasis 57 rFSH 57 recurrent sinusitis 57 elevated creatinine 57 NIASPAN 57 androgen suppression 57 extrapyramidal symptoms 57 vitreous floaters 57 cytopenias 57 mEq L 57 baseline HbA1c 57 protein tyrosine phosphatase 1B 57 hereditary pancreatitis 57 detemir 57 Nonalcoholic fatty liver 57 inflammatory biomarkers 57 unstable angina pectoris 57 Lipoprotein 57 apolipoprotein E4 57 daily subcutaneous injections 57 cardiac malformations 57 chronic pancreatitis CP 57 paricalcitol 57 metformin sulfonylurea 57 multivitamin supplementation 57 perioperatively 57 Am J Cardiol 57 baseline LDH 57 leucine isoleucine 57 selectively inhibited 57 Elitek 57 triglycerides TG 57 underwent liver transplantation 57 gestational diabetes mellitus GDM 57 aminotransferases 57 bronchial hyperresponsiveness 57 HBeAg negative 57 RRM1 57 b carotene 57 OGTT 57 Kinoid 57 CrCl 57 neurosensory 57 % CI #.#-#.# [003] 57 PRADAXA #mg 57 chorioamnionitis 57 induce orthostatic hypotension 57 neutrophil counts 57 flutamide 57 vWD 57 radioiodine therapy 57 isolated systolic hypertension 57 esophageal reflux 57 Clinically significant 57 total cholesterol triglycerides 57 Calcium intake 57 lymphocyte count 57 mm Hg diastolic 57 epigastric pain 57 deep venous thromboses 57 posttreatment 57 pancreatic insufficiency 57 aspartate aminotransferase AST 57 elevated serum creatinine 57 metformin Glucophage 57 aminotransferase levels 57 Avandia Actos 57 pyridoxine 57 hypocalcemia 57 doxorubicin cyclophosphamide 57 serum albumin 57 potassium sparing diuretics 57 hypertension dyslipidemia 57 central adiposity 57 μg kg 57 Efficacy endpoints 57 nonvertebral fractures 57 colesevelam 57 intermittent hemodialysis 57 Systemic Lupus Erythematosus SLE 57 hematopoietic cancers 57 serum markers 57 #mg/dl 57 diabetic polyneuropathy 57 serum insulin 57 urolithiasis 57 extracapsular extension 57 antiretroviral naïve 57 folate vitamin B6 57 statin monotherapy 57 univariate analysis 57 PSA nadir 57 opioid naïve 57 Naive Patients 57 Hypertriglyceridemia 57 diabetes hyperlipidemia 57 tipranavir r 57 fasting plasma glucose FPG 57 postoperative pulmonary 57 rimonabant #mg 57 bFGF 57 cardioprotective effects 57 HER2 expression 57 PON1 activity 57 â ‰ ¥ 57 creatinine levels 57 myocardial infarctions MIs 57 mediated inhibition 57 Glucophage metformin 57 hypogonadal men 57 NMIBC 57 treatment naive genotype 57 atrophic gastritis 57 valvular heart disease 57 serum aminotransferase levels 57 ginkgo biloba extract 57 receiving VELCADE 57 morphometric vertebral fractures 57 AST ALT 57 leukocyte counts 57 RAS blockers 57 Artificial pancreas 57 μmol L 57 BARACLUDE ® 57 Pioglitazone 57 kaempferol 57 Glomerular 57 HBeAg negative patients 57 antioxidant supplementation 57 rheumatoid arthritis osteoarthritis ankylosing 57 systemic corticosteroid 57 anti HBs 57 primary hyperparathyroidism 57 tonsillar hypertrophy 57 Magnesium deficiency 57 timepoints 57 bioavailable testosterone 57 hepatocellular carcinomas 57 induce insulin resistance 57 pT3 57 trastuzumab Herceptin ® 57 Myelodysplasia 57 undetectable HBV DNA 57 seropositivity 57 clinically meaningful improvement 57 vasodilatation 57 lipid profiles 57 #.#mmol L [002] 57 Fasting plasma glucose 57 alpha1 antitrypsin AAT deficiency 57 thiazolidinediones TZDs 57 pmol L 57 PPAR gamma agonist 57 Dietary intakes 57 thiopurine 57 triacylglycerol 57 amino acid metabolism 57 urinary albumin excretion 57 elevated LDH 57 posttransplant 57 diabetic kidney 57 urinary oxalate 56 MADRS score 56 CoQ 56 periodontal gum 56 Sociodemographic 56 5 HT2A 56 arterial hypertension 56 preintervention 56 patients receiving myelosuppressive 56 Adverse effects 56 Elevated triglycerides 56 hyperhomocysteinemia 56 coagulation abnormalities 56 comorbid depression 56 Secretase 56 mg Pycnogenol 56 secondary hyperparathyroidism 56 Oxidized LDL 56 revascularizations 56 acyltransferase 56 pentoxifylline 56 numbers #B# 0 56 antithyroid 56 chromosome #p# [002] 56 Alpha lipoic acid 56 milli grams 56 primary hypercholesterolemia 56 μg d 56 triglyceride TG 56 folate vitamin B# 56 tuberous sclerosis TS 56 GBA mutations 56 linoleic acid LA 56 cholestyramine 56 hepatic enzymes 56 Endothelial dysfunction 56 deoxy D 56 dietary DHA 56 Baseline characteristics 56 cytarabine daunorubicin 56 APOE e4 56 Alanine 56 Myelodysplastic Syndrome 56 p# activation 56 g dietary fiber 56 insulin sensitizing 56 HDL cholesterol concentrations 56 2 diabetes UKPDS 56 pathologic fractures 56 mutated K ras 56 abacavir Ziagen 56 HER2 overexpression 56 histologic subtype 56 receiving XGEVA 56 N acetylgalactosamine 56 hyperinsulinemia 56 transaminase levels 56 Fluid retention 56 non splenectomized 56 postintervention 56 venlafaxine XR 56 serum phosphate levels 56 hsCRP levels 56 pg ml 56 NovoLog ® Mix 56 clomipramine 56 Patients Receiving 56 colesevelam HCl 56 improves glycemic 56 abdominal irradiation 56 atazanavir ritonavir 56 metformin sulphonylurea 56 Adjuvant therapy 56 tryptase 56 hypercoagulable 56 nonmetastatic 56 ‰ ¥ 56 rheumatoid arthritis inflammatory bowel 56 ABCB1 56 severe hypoglycaemia 56 Hb A1C 56 plasma triglycerides 56 coronary stenosis 56 Singh Manoux 56 invasive lobular 56 proliferative retinopathy 56 cells uL 56 symptomatic DVT 56 Humalog ® 56 neutropenic sepsis 56 diastolic BP 56 tHcy 56 Excretion 56 systolic dysfunction 56 NATRECOR ® 56 #OHD levels 56 Ischemic heart 56 acyl CoA 56 diabetic hypertensive 56 poor metabolizers 56 affective psychosis 56 J Am Coll 56 pharmacologic intervention 56 nonobese patients 56 Symptom severity 56 C1 INH deficiency 56 lactate dehydrogenase LDH 56 diabetes mellitus T2DM 56 nasopharyngitis headache 56 nonfasting triglyceride levels 56 cholestasis 56 Kidney Int 56 elevated triglycerides 56 IOP lowering 56 adjunctive ABILIFY 56 apolipoprotein E 56 eosinophil count 56 excess blasts RAEB 56 intracranial atherosclerosis 56 ß carotene 56 histologically proven 56 Atomoxetine 56 aspartate aminotransferase 56 abnormal lipid levels 56 Acute Renal Failure 56 metformin monotherapy 56 diabetes mellitus NIDDM 56 hyperinsulinemic 56 IGFBP 56 glucose homeostasis 56 #mg/day [002] 56 See CLINICAL PHARMACOLOGY 56 HMGA1 56 nonfasting 56 p ≤ 56 coadministration 56 antiphospholipid syndrome 56 bortezomib refractory 56 smoldering myeloma 56 adiponectin levels 56 lipid parameters 56 hemoglobin A1c levels 56 lipid lowering medications 56 fluvastatin 56 headache abdominal pain 56 preeclamptic 56 fasting triglycerides 56 plasma glucose 56 null responder 56 albumin excretion rate 56 serum retinol 56 iPTH 56 lispro alone 56 atypical hemolytic uremic syndrome 56 cytoreductive nephrectomy 56 adrenalectomy 56 multivariable analysis 56 mEq 56 interstitial nephritis 56 comorbid conditions 56 Sjögren syndrome 56 sitosterol 56 concurrent ITP 56 Renal Cell Carcinoma RCC 56 Ramipril 56 Sezary syndrome 56 induce remission 56 gene APOE 56 paraneoplastic 56 tertile 56 intracerebral haemorrhage 56 tumor histology 56 alanine aminotransferase 56 retransplantation 56 affective disorders 56 male Sprague Dawley 56 elevated hsCRP 56 leiomyomas 56 hyperammonemia 56 dietary intakes 56 PAOD 56 Phenylketonuria 56 neuroprotective effects 56 coexisting illnesses 56 tumorigenicity 56 dysglycemia 56 PBMCs 56 uricase 56 dysfunction LVSD 56 hydroxyvitamin D levels 56 tranylcypromine 56 Comorbidities 56 macrovascular complications 56 gastric adenocarcinoma 56 peptide YY 56 diarrhea flatulence 56 selective receptor agonist 56 antidiabetic medications 56 pouchitis 56 ATACAND 56 DITPA 56 glargine 56 LDL HDL 56 fetuin 56 idiopathic PAH 56 renoprotective 56 NHANES III 56 hormone receptor status 56 Lp PLA 2 56 moderate renal impairment 56 APTIVUS r 56 neurological abnormalities 56 homozygotes 56 prostate carcinoma 56 heparanase 56 euthymic 56 glucose intolerant 56 hydroxy vitamin D 56 subclinical hypothyroidism 56 Gliclazide 56 quetiapine Seroquel 56 Heterozygous Familial Hypercholesterolemia 56 mg q#h 56 fructose intolerance 56 magnesium phosphorous 56 IDDM 56 NovoMix ® 56 + PH# 56 SIADH 56 Juvenile Idiopathic Arthritis 56 peak VO2 56 GSTT1 56 Cholinesterase Inhibitors 56 Chronic pancreatitis 56 ALT flares 56 serum estradiol 56 Thiamine 56 insulin sulfonylureas 56 abnormal glucose tolerance 56 edifoligide 56 colorectal liver metastases 56 pyelonephritis 56 polyarticular 56 NYHA Class II 56 Heme iron 56 glycogen storage 56 oxcarbazepine 56 hematologic toxicity 56 Slows Progression 56 creatinine ratio 55 olmesartan 55 non valvular atrial 55 LV dysfunction 55 treatment naïve genotype 55 pulmonary metastases 55 Flu Cy 55 apo B 55 Lipitor #mg 55 vitamin D calcium 55 renovascular hypertension 55 parkinsonian 55 carbohydrate intolerance 55 thiamin riboflavin 55 heterozygotes 55 Am J Clin 55 adipokine 55 genotypic resistance 55 NAT2 55 liver steatosis 55 glycated 55 dyslipidemia hypertension diabetes 55 hippocampal atrophy 55 Multivariate analysis 55 subclinical atherosclerosis 55 lipohypertrophy 55 Dietary fiber 55 serum parathyroid hormone 55 pharmacodynamic parameters 55 either acutely decompensated 55 MMSE score 55 liver transplant recipients 55 glucosylceramide 55 hyperparathyroidism 55 hepatic cirrhosis 55 STRIDE PD 55 serum GGT 55 #.#mg/dL 55 Infusion Reactions Severe 55 symptomatic intracranial 55 multivariable adjusted 55 nadroparin 55 hemodilution 55 postoperative AF 55 gallstone disease 55 folic acid vitamin B# 55 hemodynamically significant 55 coronary revascularization procedures 55 foot ulcers DFU 55 IGF binding 55 T2DM 55 corticosteroid therapy 55 adjunctive placebo 55 generalized edema 55 Inflammatory diseases 55 NNRTI resistance 55 cefotaxime 55 nonalcoholic steatohepatitis NASH 55 intravascular hemolysis 55 bisoprolol 55 malondialdehyde 55 atrioventricular block 55 rizatriptan 55 cranial irradiation 55 CP CPPS 55 plasminogen activator inhibitor 55 leptin deficient mice 55 L lysine 55 thromboxane A2 55 serum IGF 55 antitumor efficacy 55 neurodevelopmental outcomes 55 oral hypoglycemic agents 55 fatigue asthenia 55 5alpha reductase 55 hydroxylase 55 prostate cancer CaP 55 PsA 55 bacteriuria 55 differentially regulated 55 motilin 55 Cognitive impairment 55 Patients Treated With 55 PROactive study 55 advanced adenoma 55 statins cholesterol lowering 55 HER2 positivity 55 1 diabetes T1D 55 Insulin sensitizers 55 preoperative PSA 55 immune thrombocytopenic purpura 55 placebo dummy pill 55 gestational hypertension 55 VLDL C 55 LUTS 55 plasma homocysteine 55 mmol l 55 aldosterone antagonist 55 lymphoproliferative disorders 55 corticosteroid dose 55 Dental caries 55 erythropoietic 55 prolactin levels 55 hyperprolactinemia 55 myeloproliferative diseases 55 mmol liter 55 dietary carbohydrate 55 intravenous cyclophosphamide 55 ß amyloid 55 inducible nitric oxide synthase 55 thrombocytopenic 55 monocyte chemotactic protein 55 % CI #.#-#.# [001] 55 nondemented 55 glycemia 55 elevated uric acid 55 pretreatment baseline 55 metabolic acidosis 55 basal cell nevus syndrome 55 unresectable HCC 55 Diabetic neuropathy 55 serum uric acid 55 silent myocardial ischemia 55 ACTOS ® 55 elevated LDL cholesterol 55 lactate dehydrogenase 55 bronchodilatory 55 folic acid vitamin B6 55 type2 diabetes 55 drug eluting stent implantation 55 venlafaxine Effexor 55 transfusion syndrome 55 diabetes mellitus 55 oral hypoglycemics 55 -#.# ± [002] 55 Hashimoto thyroiditis 55 Neovascular Age Related Macular 55 treatment emergent hyperglycemia 55 arginine vasopressin AVP 55 recurrent VTE 55 iobenguane 55 pravastatin Pravachol 55 cough dyspnea 55 lipid lowering medication 55 microvascular dysfunction 55 vascular reactivity 55 deferiprone 55 SGLT 55 lipid abnormalities 55 multisystem disease 55 BEXXAR Therapeutic Regimen 55 pressure natriuresis 55 Calcium absorption 55 isoproterenol 55 GnRH agonist 55 antiretroviral naive 55 microalbumin 55 hepatocellular carcinoma liver 55 urine albumin 55 carotid plaque 55 Genetic variants 55 pharmacokinetic equivalence 55 eicosapentaenoic acid 55 serum glucose 55 Adenomas 55 PASI scores 55 uremic pruritus 55 UCP1 55 metabolic abnormalities 55 dyslipidemia hypertension 55 #mg BID [001] 55 severe hepatic insufficiency 55 approved incretin mimetic 55 fractional shortening 55 glitazone class 55 postprandial insulin 55 pancreatic alpha 55 rosiglitazone maleate 55 fasting glucose levels 55 lymphomas leukemias 55 SGRQ 55 neuropathy sensory 55 activated microglia 55 chronic pancreatitis 55 oxidative stress markers 55 β blocker 55 Lymphocytic 55 abstr 55 prucalopride 55 abnormal glucose metabolism 55 AFREZZA ™ 55 endometrial hyperplasia 55 subcutaneous insulin 55 Combination therapy 55 thromboembolic complications 55 thromboembolic 55 lupus anticoagulant 55 hypocaloric diet 55 CTEPH 55 suppl. 55 esophageal squamous cell carcinoma 55 hypothalamic amenorrhea 55 mg calcium 55 metastatic malignant 55 Non Alcoholic Steatohepatitis 55 MMSE scores 55 PUFA intake 55 obstructive coronary artery 55 comorbid ADHD 55 dosing cohort 55 variceal bleeding 55 potent suppressor 55 renal cysts 55 glucose triglycerides 55 rs# [004] 55 hematologic abnormalities 55 Abstract P# [002] 55 certolizumab 55 DRD2 55 sensory neuropathy 55 glycogen synthesis 55 nocturnal hypoglycaemia 55 proliferator activated receptor 55 hypoxia induced 55 benazepril 55 aldosterone antagonists 55 GSTP1 55 Hydralazine 55 biphasic insulin aspart 55 neuroregenerative 55 calcaneal fractures 55 rhGH 55 nonobese 55 0mg 55 silibinin 55 lipid levels 55 plasma folate 55 dose statin therapy 55 bile acid metabolism 55 hippocampal volumes 55 intima media thickness 55 probiotic supplementation 55 APTIVUS ritonavir 55 adrenal suppression 55 serum lipids 55 fusion enhancers 55 Cardio vascular 55 carotid bruit 55 dietary folate 55 QTcF 55 moderate hepatic impairment 55 intracerebral hemorrhage ICH 55 oral antidiabetic agents 55 alcoholic fatty liver 55 Hepatitis C Genotype 55 Gonadotropin 55 potassium excretion 55 overt hypothyroidism 55 kidney insufficiency